Selected research publications
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trial – Journal: The Lancet Microbe – Published: 13th February 2026
Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial – Journal: The Lancet Neurology – Published: 1st February 2026
The effect of Pneumococcal Conjugate Vaccine and Pneumococcal Polysaccharide Vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B: a randomised controlled trial – Journal: The Lancet Microbe – Published: 29th September 2025
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial: a randomised, controlled, open-label, platform trial – Journal: The Lancet Child & Adolescent Health – Published: 1st March 2024
Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3) – Journal: BMJ Open – Published: 10th January 2024
View more publications